Search

ONCTERNAL THERAPEUTICS REPORTS GRANTING OF AN INDUCEMENT AWARD UNDER NASDAQ LISTING RULE 5635(4)

SAN DIEGO, Feb. 22, 2021 - Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of...

ONCTERNAL ANNOUNCES THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

SAN DIEGO, Nov. 04, 2020 - Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of...